0

Superficial & Orthovoltage Radiotherapy for the Treatment of Non-Melanoma Skin Cancer and Other Benign Conditions

Non-melanoma skin cancer is the most common cancer in the world today, with approximately 1.5 million cases in 2016—and that number is growing rapidly. While this type of cancer has a low [...]

0

Tech Talk: Who is the Ideal Candidate for Radiation Therapy? 

Adrian Treverton, Chief Executive Officer of Xstrahl, speaks about the types of patients who are the best candidates for radiation therapy. Patients often prefer radiation therapy over surgery [...]

0

Using Superficial X-Rays to Treat Keloid Scarring

Explore how radiotherapy can be used to treat keloid scarring in this presentation by Dr. Richard Shaffer.

0

Xstrahl in Action: Xstrahl 300 Used to Treat NMSC with Hypofractionated Radiotherapy

This study, Hypofractionated Radiotherapy in Older Patients with Non-melanoma Skin Cancer: Less is Better, explores how our Xstrahl 300 system was used to successfully treat NMSC for 3 older [...]

0

Xstrahl in Action: Re-excision of BCCs

Orthovoltage X-rays, as offered by the Xstrahl 300, provides an excellent alternative to re-excision for incompletely resected or recurrent BCCs Surgery is the gold standard treatment for basal [...]

0

Xstrahl 200 Enables Gold Nanoparticle Research

Kilo-voltage X-ray therapy has long established itself as a highly effective method for treating non-melanoma skin cancer and a number of other oncology diseases. One of the most interesting [...]

0

Xstrahl in Action: Multi-Disciplinary Management of Non-Melanoma Skin Cancer

In this video, Dr. Bernad, of Disney Family Cancer Center, discusses his experiences using the Xstrahl 100 device for treating skin cancer. This was recorded at Hope Cancer Center and comes from [...]

0

Xstrahl In Action: Xstrahl 150 used in study on Arthroses on Dogs

Radiation therapy in benign diseases, particularly in arthroses, has been used as a successful treatment method in human medicine for more than one hundred years. In their study [...]

0

Xstrahl In Action: Xstrahl 200 used in study into pituitary tumors in animals

In their study “Effektivität der Strahlentherapie in der Behandlung von hypophysären Tumoren bei 13 Hunden” Simona Mayer-Stankeová , Carla Rohrer Bley , Melanie Wergin , Nadja Sieber-Ruckstuhl , [...]

0

Xstrahl In Action: Xstrahl 200 Used for Research into Clinical Response Following Superficial Radiation Therapy of SCCs

Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin cancer and arises from abnormal growth in the squamous cells of the skin’s outermost layer due to cumulative [...]

page 1 of 4